Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejitCrsecrAToEcNRZhA

February 4, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
  Legislative & Regulatory News 
  • Agency releases final Sunshine Act rule
    CMS on Friday released the final rule for the Physician Payments Sunshine Act, requiring drug and device companies to gather information on gifts, payments and other value transfers provided to doctors and teaching hospitals starting Aug. 1. The rule also requires manufacturers and group purchasing organizations to report ownership and investment interests by physicians. Modern Healthcare (subscription required) (2/1) LinkedInFacebookTwitterEmail this Story
  • Study finds large premium increases for some under ACA
    Premiums for individual health insurance plans for young, healthy men are likely to rise as a result of the Affordable Care Act, though some will receive federal subsidies to offset some of the cost. A survey by the American Action Forum, a group that opposes the ACA, found premiums for an individual policy offering minimal coverage could rise 190% for a 27-year-old nonsmoking male. Politico (Washington, D.C.) (2/4) LinkedInFacebookTwitterEmail this Story
  • Study finds disparity in how doctors prescribe heart drugs
    Americans without health coverage are 6% to 12% less likely than those who have insurance to be prescribed drugs for heart disease, according to a study published in the Journal of the American College of Cardiology. Patients treated at clinics where many uninsured patients receive care were the least likely to be prescribed heart drugs. Reuters (2/1) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • Report maps psychiatric drug use in the U.S.
    Use of antipsychotics, antidepressants and stimulants is 40% greater in parts of the southern U.S. than in other regions, researchers wrote in the journal Health & Place, while patients living in the western U.S. are least likely to take psychiatric medications. "Our work suggests that access to clinical care and pharmaceutical marketing may be critical for understanding who gets treated and how they get treated," said Marissa King of Yale University. HealthDay News (2/1) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
To attain knowledge, add things every day. To attain wisdom, subtract things every day."
--Laozi,
Chinese philosopher


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information